SULLIVAN TIMOTHY EUGENE (Chief Financial Officer) received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2026ACC: 0001492422-26-000073
Officer· Chief Financial Officer
Since Feb 2019
+58.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
58.14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+58.14K
Price / share
—
Trade value
—
% of position
61.9%
1/28/2026
93.90K→152.04K
Total
Net shares
+58.14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/28/2026 | A · Award | +58.14K | — | — | 61.9% | 93.90K | 152.04K |
| Total | +58.14K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned60.40K
Total
60.40K indirect60.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60.40K | Indirect |
| Total | 60.40K | 60.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported